期刊文献+

人附睾蛋白4基因表达下调对卵巢癌细胞生物学行为的影响 被引量:5

Effect of down-regulation of HE4 gene expression on biologic behavior of ovarian cancer cells
原文传递
导出
摘要 目的探讨人附睾蛋白4(HFA)基因表达下调对卵巢癌细胞增殖、黏附以及侵袭能力的影响。方法构建含HEdshDNA的重组质粒,并将其转染卵巢癌细胞系SKOV3细胞,RNA干扰后,通过即时定量聚合酶链反应(qRT—PCR)、Western blot等测定HFA表达下调情况;同时利用平板克隆形成实验、细胞黏附实验、测定稳定转染细胞的侵袭力改变等方法,比较分析HE4相关的生物学效应。结果Western blot以及qRT—PCR结果均提示HFA干扰重组质粒构建成功,稳定转染SKOV3细胞后能显著抑制HFA基因的表达。体外实验显示,HE4表达下调的细胞侵袭能力明显下降(P〈0.05),黏附率明显下降到27.3%,而增殖能力较转染前无明显变化。结论所构建的HFA干扰重组表达载体能有效抑制HFA基因表达,而HFA表达下调对卵巢癌的细胞黏附和侵袭能力降低。 Objective To investigate the effects of HE4 gene knockdown on the proliferation, adhesion and invasion of the ovarian cancer cells SKOV3. Methods The knockdown of HE4 gene was performed by RNAi technology. The recombinant plasmids (pSUPER-HE4 shDNAs) were constructed and transfected into human ovarian cancer cells SKOV3. HE4 expression was then identified by real-time PCR and Western blot analysis. The invasion and adhesion ability of transduced cells were determined. In addition, cell proliferation and growth were analyzed by colonies formation assay. Results Knockdown of HE4 was achieved, and further confirmed by real-time PCR and Western blot. The proliferation of HE4- down-regulated cells was not affected, but the invasion ability of the transfected cells was reduced (P 〈 0. 05 ) and the adhesion ability was also reduced to 27.3%. Conclusion HE4 expression is down-regulated effectively by the constructed HE4 shDNA, and thus knockdown of HE4 inhibits the adhesion and invasion of SKOV3 cells.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2013年第10期687-690,共4页 Chinese Journal of Pathology
基金 上海市科委基金(124119a0202,114119a0400)
关键词 卵巢肿瘤 肿瘤标记 生物学 RNA干扰 Ovarian neoplasms Tumor markers, biological RNA interference
  • 相关文献

参考文献4

二级参考文献29

  • 1单景庆.抑癌基因PTEN与子宫内膜癌的研究进展[J].现代肿瘤医学,2006,14(7):900-901. 被引量:4
  • 2Ozols RF, Bookman MA, Connolly DC, et al, Focus on epithelial ovarian cancer. Cancer Cell, 2004,5 : 19-24.
  • 3Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002,359: 572-577.
  • 4Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HFA (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003, 63:3695-3700.
  • 5Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol, 2009,112:40-46.
  • 6Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 1991, 45:350-357.
  • 7Drapkin R,Von Horsten HH, Lin YF, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005,65:2162-2169.
  • 8Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol, 2008,108:402-408.
  • 9Drapkin R,Hecht JL.The origins of ovarian cancer,hurdles and progress[J].Women's Oncol Rev,2002,2(1):261-268.
  • 10Pickle LW,Hao Y,Jemal A,et el.A new method of estimating United States and state-level cancer incidence counts for the current calendar year[J].CA Cancer J Clin,2007,57(1):30-42.

共引文献79

同被引文献25

  • 1Ashish P Wasnik,Christine O Menias,Joel F Platt,Usha R Lalchandani,Deepak G Bedi,Khaled M Elsayes.Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach[J].World Journal of Radiology,2013,5(3):113-125. 被引量:7
  • 2Ya-Fei Zhu,Guo-Lan Gao,Sheng-Bo Tang,Zhen-Dong Zhang,Qing-Shui Huang.Effect of WFDC 2 silencing on the proliferation,motility and invasion of human serous ovarian cancer cells in vitro[J].Asian Pacific Journal of Tropical Medicine,2013,6(4):265-272. 被引量:12
  • 3MOORE RG,MILLER MC,STEINHOFF MM,et al.Serum HE4levels are less frequently elevated than CA125 in women with benign gynecologic disorders[J].Am J Obstet Gynecol,2012,206(4):351.e1-8.
  • 4HOLCOMB K,VUCETIC Z,MILLER C,et al.Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women[J].Am J Obstet Gynecol,2011,205(4):358.e1-6.
  • 5KIRCHHOFF C,HABBEN I,IVELL R,et al.A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J].Biol Reprod,1991,45(2):350-357.
  • 6KIRCHHOFF C.Molecular characterization of epididymal proteins[J].Rev Reprod,1998,3(2):86-95.
  • 7DRAPKIN R,VON HORSTEN HH,LIN Y,et al.Human epididymis protein 4(HE4)is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J].Cancer Res,2005,65(6):2162-2169.
  • 8GALGANOMT,HAMPTON GM,FRIERSON HF JR.Comprehensive analysis of HE4 expression in normal and malignant human tissues[J].Mod Pathol,2006,19(6):847-853.
  • 9GEORGAKOPOULOS P,MEHMOOD S,AKALIN A,et al.Immunohistochemical localization of HE4 in benign,borderline,and malignant lesions of the ovary[J].Int J Gynecol Pathol,2012,31(6):517-523.
  • 10ZHUANG Huiyu,GAO Jian,HU Zhenhua,et al.Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma[J].PLoS ONE,2013,8(7):e68994.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部